EFFECTS OF CHOLESTYRAMINE AND COLESTIPOL ON THE PLASMA-CONCENTRATIONS OF PROPRANOLOL

被引：22

作者：

HIBBARD, DM

PETERS, JR

HUNNINGHAKE, DB

机构：

[1] UNIV MINNESOTA,DEPT PHARMACOL,MINNEAPOLIS,MN 55455

[2] UNIV MINNESOTA,DEPT MED,MINNEAPOLIS,MN 55455

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1984年 / 18卷 / 03期

关键词：

D O I：

10.1111/j.1365-2125.1984.tb02473.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：337 / 342

页数：6

共 16 条

[1] INTERRUPTION OF ENTEROHEPATIC CIRCULATION OF DIGITOXIN BY CHOLESTYRAMINE .1. PROTECTION AGAINST LETHAL DIGITOXIN INTOXICATION [J].

CALDWELL, JH ;

GREENBER.NJ .

JOURNAL OF CLINICAL INVESTIGATION, 1971, 50 (12) :2626-+

[2] EFFECT OF METOCLOPRAMIDE ON THE BIOAVAILABILITY OF LONG-ACTING PROPRANOLOL [J].

CHARLES, BG ;

RENSHAW, PJ ;

KAY, JJ ;

RAVENSCROFT, PJ .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (05) :517-518

[3]

COTHAM RH, 1975, CLIN PHARMACOL THER, V18, P535

[4]

DOBBS JH, 1977, CURR THER RES CLIN E, V21, P887

[5]

GALLO DG, 1965, P SOC EXP BIOL MED, V120, P60

[6]

GRABOWSKI BS, 1980, INT J CLIN PHARM TH, V18, P317

[7]

GYSELINCK P, 1980, BRIT J CLIN PHARMACO, V10, P406

[8]

HUNNINGHAKE DB, 1978, PHARMACOLOGIST, V20, P220

[9]

HUNNINGHAKE DB, 1977, HYPERLIPIDEMIA DIAGN, P327

[10]

HUNNINGHAKE DB, 1980, CARDIOVASCULAR RESPI, P79

← 1 2 →